1 / 7

XELJANZ(tofacitinib)

XELJANZ(tofacitinib) is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis.<br>

Alleviare
Télécharger la présentation

XELJANZ(tofacitinib)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ALLEVIARELIFESCIENCES PVT.LIMITED It's a pharmaceutical distribution and marketing company based in operations, Pan India. We are also a service providing company for patients, doctors, hospitals and government hospitals. Alleviare help in finding sources and assisting with documentation work for procuring medicines under, Named Patient Program/Managed Access Program/Early Access Program. Delhi (INDIA) having

  2. XELJANZ(TOFACITINIB) XELJANZ(tofacitinib) is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis.

  3. WHATISXELJANZ (TOFACITINIB)? XELJANZ (Tofacitinib) is the active ingredient of Xeljanz, is an immunosuppressant that blocks the action of Janus kinases, enzymes that play a crucial role in the process of inflammation and damage of the joints. Tofacitinib, by blocking the enzymes, reduces the inflammation and other symptoms of rheumatoid arthritis

  4. HOWTOBUYXELJANZ (TOFACITINIB) ININDIA? XELJANZ (Tofacitinib) Tablets suppliers in India. Allevaire India New Delhi, INDIA. Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

  5. WHATARETHEINDICATIONS ANDUSAGE? XELJANZ is a prescription medicine called a Janus kinase (JAK) inhibitor. XELJANZ is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well. It is not known if XELJANZ is safe and effective in people with Hepatitis B or C. XELJANZ is not for people with severe liver problems. It is not known if XELJANZ is safe and effective in children.

  6. WHATARETHEFACTSOF XELJANZ (TOFACITINIB) ? Medicine Name: XELJANZ Generic Name: Tofacitinib Approval Date: Aug 21, 2012. Available as (Form & Strength): Tablets: 5 mg Tablets Company Name: Pfizer Labs.

  7. THANK YOU Alleviare Life Sciences Pvt. Ltd. S-1/5 First Floor, Uphaar Cinema Complex Market, Green Park Extn., South Delhi, New Delhi- 110016 kamal@alleviarelife.com Call Us: +91-9818274099

More Related